Literature DB >> 30239654

The Epidemiology and Clinical Features of Balamuthia mandrillaris Disease in the United States, 1974-2016.

Jennifer R Cope1, Janet Landa1,2, Hannah Nethercut1,3, Sarah A Collier1, Carol Glaser4, Melanie Moser5, Raghuveer Puttagunta1, Jonathan S Yoder1, Ibne K Ali1, Sharon L Roy6.   

Abstract

BACKGROUND: Balamuthia mandrillaris is a free-living ameba that causes rare, nearly always fatal disease in humans and animals worldwide. B. mandrillaris has been isolated from soil, dust, and water. Initial entry of Balamuthia into the body is likely via the skin or lungs. To date, only individual case reports and small case series have been published.
METHODS: The Centers for Disease Control and Prevention (CDC) maintains a free-living ameba (FLA) registry and laboratory. To be entered into the registry, a Balamuthia case must be laboratory-confirmed. Several sources were used to complete entries in the registry, including case report forms, CDC laboratory results, published case reports, and media information. SAS© version 9.3 software was used to calculate descriptive statistics and frequencies.
RESULTS: We identified 109 case reports of Balamuthia disease between 1974 and 2016. Most (99%) had encephalitis. The median age was 36 years (range 4 months to 91 years). Males accounted for 68% of the case patients. California had the highest number of case reports, followed by Texas and Arizona. Hispanics constituted 55% for those with documented ethnicity. Exposure to soil was commonly reported. Among those with a known outcome, 90% of patients died.
CONCLUSIONS: Balamuthia disease in the United States is characterized by a highly fatal encephalitis that affects patients of all ages. Hispanics were disproportionately affected. The southwest region of the United States reported the most cases. Clinician awareness of Balamuthia as a cause of encephalitis might lead to earlier diagnosis and initiation of treatment, resulting in better outcomes. Published by Oxford University Press for the Infectious Diseases Society of America 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  zzm321990 Balamuthia mandrillariszzm321990 ; free-living ameba; granulomatous amebic encephalitis

Mesh:

Year:  2019        PMID: 30239654      PMCID: PMC7453664          DOI: 10.1093/cid/ciy813

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

1.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Transmission of Balamuthia mandrillaris by Organ Transplantation.

Authors:  Eileen C Farnon; Kenneth E Kokko; Philip J Budge; Chukwuma Mbaeyi; Emily C Lutterloh; Yvonne Qvarnstrom; Alexandre J da Silva; Wun-Ju Shieh; Sharon L Roy; Christopher D Paddock; Rama Sriram; Sherif R Zaki; Govinda S Visvesvara; Matthew J Kuehnert; Joli Weiss; Ken Komatsu; Richard Manch; Alberto Ramos; Leonor Echeverria; Ann Moore; Phil Zakowski; Michelle Kittleson; Jon Kobashigawa; Jonathan Yoder; Michael Beach; William Mahle; Kirk Kanter; P J Geraghty; Eileen Navarro; Christine Hahn; Shiro Fujita; Jim Stinson; Joel Trachtenberg; Paul Byers; Michele Cheung; Tun Jie; Bruce Kaplan; Rainer Gruessner; Erica Bracamonte; Chad Viscusi; Regino Gonzalez-Peralta; Robert Lawrence; Jonathan Fratkin; Fauzia Butt
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

3.  Serologic survey for exposure following fatal Balamuthia mandrillaris infection.

Authors:  Brendan R Jackson; Zuzana Kucerova; Sharon L Roy; Glenda Aguirre; Joli Weiss; Rama Sriram; Jonathan Yoder; Rebecca Foelber; Steven Baty; Gordana Derado; Susan L Stramer; Valerie Winkelman; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2014-01-24       Impact factor: 2.289

4.  Fatal infections with Balamuthia mandrillaris (a free-living amoeba) in gorillas and other Old World primates.

Authors:  B A Rideout; C H Gardiner; I H Stalis; J R Zuba; T Hadfield; G S Visvesvara
Journal:  Vet Pathol       Date:  1997-01       Impact factor: 2.221

5.  Balamuthia mandrillaris meningoencephalitis: survival of a pediatric patient.

Authors:  Larry Curtis Cary; Erich Maul; Chrystal Potter; Peter Wong; Peter T Nelson; Curtis Given; William Robertson
Journal:  Pediatrics       Date:  2010-02-01       Impact factor: 7.124

6.  Presence of potentially pathogenic free-living amoebae strains from well water samples in Guinea-Bissau.

Authors:  Rocío A Baquero; María Reyes-Batlle; Graciela G Nicola; Carmen M Martín-Navarro; Atteneri López-Arencibia; J Guillermo Esteban; Basilio Valladares; Enrique Martínez-Carretero; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathog Glob Health       Date:  2014-06-17       Impact factor: 2.894

Review 7.  Increasing importance of Balamuthia mandrillaris.

Authors:  Abdul Matin; Ruqaiyyah Siddiqui; Samantha Jayasekera; Naveed Ahmed Khan
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Isolation of Balamuthia mandrillaris from urban dust, free of known infectious involvement.

Authors:  Maryam Niyyati; Jacob Lorenzo-Morales; Mostafa Rezaeian; Carmen M Martin-Navarro; Afsaneh Motevalli Haghi; Sutherland K Maciver; Basilio Valladares
Journal:  Parasitol Res       Date:  2009-12       Impact factor: 2.289

9.  Centrofacial Balamuthiasis: case report of a rare cutaneous amebic infection.

Authors:  Oliver H Chang; Fan Liu; Eleanor Knopp; Atis Muehlenbachs; Jennifer R Cope; Ibne Ali; Robert Thompson; Evan George
Journal:  J Cutan Pathol       Date:  2016-07-12       Impact factor: 1.587

10.  Balamuthia amebic encephalitis risk, Hispanic Americans.

Authors:  Frederick L Schuster; Carol Glaser; Somayeh Honarmand; James H Maguire; Govinda S Visvesvara
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  20 in total

1.  In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria and Pathogen Boxes To Discover Novel Compounds with Activity against Balamuthia mandrillaris.

Authors:  Christopher A Rice; Luis Fernando Lares-Jiménez; Fernando Lares-Villa; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 2.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

3.  Fatal Balamuthia mandrillaris infection with red plaques on the nasal dorsum as the first presentation.

Authors:  Kang Tao; Ting Wang; Lian Zhang; Xi-Chuan Yang; Zhi-Fang Zhai
Journal:  An Bras Dermatol       Date:  2022-06-09       Impact factor: 2.113

4.  Diagnostic evaluation of fatal Balamuthia mandrillaris meningoencephalitis in a captive Bornean orangutan (Pongo pygmaeus) with identification of potential environmental source and evidence of chronic exposure.

Authors:  Shawna J Hawkins; Jason D Struthers; Kristen Phair; Ibne Karim M Ali; Shantanu Roy; Bonnie Mull; Gary West
Journal:  Primates       Date:  2020-09-12       Impact factor: 2.163

5.  Rapid Cerebral Edema and Herniation in a 65-Year-Old Man With Balamuthia Mandrillaris.

Authors:  Michael Zwillman; Anh T Nguyen; Natalie Organek; Zoulficar A Kobiessi; Sudha Kodali; Kevin E Immanuel
Journal:  Cureus       Date:  2021-04-15

6.  Balamuthia mandrillaris infection: report of 1st autochthonous, fatal case in Italy.

Authors:  Carolina Saffioti; Alessio Mesini; Roberta Caorsi; Mariasavina Severino; Marco Gattorno; Elio Castagnola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-20       Impact factor: 3.267

7.  Opportunistic free-living amoebal pathogens.

Authors:  Mohammad Ridwane Mungroo; Naveed Ahmed Khan; Sutherland Maciver; Ruqaiyyah Siddiqui
Journal:  Pathog Glob Health       Date:  2021-10-02       Impact factor: 3.735

8.  Rapid, Noninvasive Diagnosis of Balamuthia mandrillaris Encephalitis by a Plasma-Based Next-Generation Sequencing Test.

Authors:  Gautam Kalyatanda; Kenneth Rand; Martin S Lindner; David K Hong; Mehmet Sait Albayram; Jason Gregory; Jesse Kresak; Karim M Ali Ibne; Jennifer R Cope; Shantanu Roy; Joy M Gary; Varalakshmi Reddy; Asim A Ahmed
Journal:  Open Forum Infect Dis       Date:  2020-06-01       Impact factor: 3.835

Review 9.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

10.  Infections Caused by Free-Living Amoebae.

Authors:  Aaron Kofman; Jeannette Guarner
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.